(Q34460547)

2 August 2017

1 reference

title

Neurobiology and neurochemistry of Rett syndrome. (English)

1 reference

2 August 2017

0 references

0 references

Matsuishi T

1

1 reference

2 August 2017

Yamashita Y

series ordinal

2

1 reference

2 August 2017

Kusaga A

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

1 December 2001

1 reference

2 August 2017

published in

Brain and Development

1 reference

2 August 2017

volume

23 Suppl 1

1 reference

2 August 2017

page(s)

S58-61

1 reference

Diagnostic criteria for Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Pathophysiology of Rett syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Rett syndrome: neurobiological changes underlying specific symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Rett syndrome: biogenic amines and metabolites in postmortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Alterations in dopaminergic function in Rett syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Altered cholinergic function in the basal forebrain of girls with Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Development of amino acid receptors in frontal cortex from girls with Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Elevated CSF glutamate in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Rett syndrome: findings suggesting axonopathy and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

The Rett syndrome and CSF lactic acid patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Membrane cerebral lipids in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Human brain gangliosides: developmental changes from early fetal stage to advanced age.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Substance P in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Substance P immunoreactivity in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Neurotrophic effects of substance P on hippocampal neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Phenylethylaminergic mechanisms in attention-deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Decreased beta-phenylethylamine in CSF in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2801%2900380-1

7 January 2021

10.1016/S0387-7604(01)00380-1

Identifiers

DOI

1 reference

2 August 2017

1 reference